zalcitabine has been researched along with Allodynia in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Aly, E; Khajah, MA; Masocha, W | 1 |
| Allegue, C; Brea, J; Burgueño, J; Carracedo, Á; Cimadevila, M; Cruz, R; Domínguez, E; Loza, MI; Martínez, AL; Merlos, M; Monroy, X; Varela, MJ | 1 |
| Fang, Z; Gao, Y; Jia, T; Li, G; Liang, S; Liu, S; Ouyang, S; Wang, S; Wu, B; Xie, L; Xu, C; Xu, H; Xue, Y; Yi, Z; Yuan, H; Zhang, C; Zhao, S; Zhou, C; Zou, L | 1 |
| Lau, T; Rice, AS; Smith, MT; Wallace, VC; Wyse, BD | 1 |
| Candiotti, KA; Hao, S; Huang, W; Levitt, RC; Liu, S; Lubarsky, DA; Ouyang, H; Yi, H; Zeng, W; Zheng, W | 1 |
| Galeotti, N; Ghelardini, C; Quattrone, A; Sanna, MD | 1 |
| Galeotti, N; Ghelardini, C; Mello, T; Quattrone, A; Sanna, MD | 1 |
| Galeotti, N; Ghelardini, C; Peroni, D; Quattrone, A; Sanna, MD | 1 |
| Galeotti, N; Ghelardini, C; Sanna, MD | 1 |
| Hao, S; Huang, W; Iida, T; Kanda, H; Liu, S; Lubarsky, DA; Yi, H | 1 |
| Ferrari, LF; Levine, JD | 1 |
| Bogen, O; Chum, A; Ferrari, LF; Levine, JD; Reichling, DB | 1 |
| Blackbeard, J; Field, MJ; Hasnie, F; O'Dea, KP; Pheby, T; Rice, AS; Segerdahl, A; Takata, M; Wallace, VC | 1 |
| Joseph, EK; Levine, JD | 2 |
| Blackbeard, J; Hasnie, F; McMahon, SB; Pheby, T; Rice, AS; Segerdahl, AR; Wallace, VC | 1 |
| Alessandri-Haber, N; Dina, OA; Green, PG; Khasar, SG; Levine, JD; Messing, RO | 1 |
17 other study(ies) available for zalcitabine and Allodynia
| Article | Year |
|---|---|
β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
Topics: Animals; Brain; Disease Models, Animal; Female; Humans; Hyperalgesia; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neuralgia; Polycyclic Sesquiterpenes; Receptor, Cannabinoid, CB2; Reverse Transcriptase Inhibitors; Skin; Zalcitabine | 2019 |
Identification of Novel Regulators of Zalcitabine-Induced Neuropathic Pain.
Topics: Animals; Calcium Signaling; Disease Models, Animal; Ganglia, Spinal; Humans; Hyperalgesia; Neuralgia; Quality of Life; Sensory Receptor Cells; Zalcitabine | 2021 |
P2Y
Topics: Animals; Anti-HIV Agents; Ganglia, Spinal; HIV Envelope Protein gp120; HIV Infections; Hyperalgesia; Male; Neuralgia; Neuroglia; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Up-Regulation; Zalcitabine | 2018 |
Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy.
Topics: Analgesics; Angiotensin II Type 2 Receptor Blockers; Animals; Anti-HIV Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Hot Temperature; Hyperalgesia; Imidazoles; Male; Neuralgia; Polyneuropathies; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sciatic Neuropathy; Time Factors; Touch; Zalcitabine | 2014 |
Mechanical allodynia induced by nucleoside reverse transcriptase inhibitor is suppressed by p55TNFSR mediated by herpes simplex virus vector through the SDF1α/CXCR4 system in rats.
Topics: Animals; Chemokine CXCL12; Hyperalgesia; Male; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Inhibitors; Simplexvirus; Spinal Cord; Up-Regulation; Zalcitabine | 2014 |
PKC-mediated HuD-GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy.
Topics: Animals; Anti-HIV Agents; Brain; Disease Models, Animal; ELAV Proteins; ELAV-Like Protein 4; GAP-43 Protein; Hyperalgesia; Male; Mice; Pain; Peripheral Nervous System Diseases; Protein Kinase C; Reverse Transcriptase Inhibitors; Zalcitabine | 2014 |
The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy.
Topics: Animals; Anti-Retroviral Agents; Cells, Cultured; Disease Models, Animal; ELAV Proteins; GAP-43 Protein; Gene Expression Regulation; Hyperalgesia; Male; Mice; Neurons; Oligodeoxyribonucleotides, Antisense; Pain; Peripheral Nervous System Diseases; Phosphopyruvate Hydratase; Protein Kinase C; Spinal Cord; Time Factors; Zalcitabine | 2014 |
Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy.
Topics: Analgesics, Non-Narcotic; Animals; Anti-HIV Agents; Apomorphine; Calcium Channel Blockers; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; ELAV Proteins; ELAV-Like Protein 4; Exploratory Behavior; Gene Expression Regulation; Hyperalgesia; Male; Mice; Motor Activity; Neuroblastoma; Pain; Pain Threshold; Peripheral Nervous System Diseases; Ryanodine Receptor Calcium Release Channel; Spinal Cord; Zalcitabine | 2015 |
Blockade of the spinal BDNF-activated JNK pathway prevents the development of antiretroviral-induced neuropathic pain.
Topics: Animals; Anthracenes; Anti-Retroviral Agents; Brain-Derived Neurotrophic Factor; Caspase 3; Cold Temperature; Hyperalgesia; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; Models, Animal; Neuralgia; Protein Kinase Inhibitors; Random Allocation; Spinal Cord; Stavudine; Touch; Zalcitabine | 2016 |
Spinal CPEB-mtROS-CBP signaling pathway contributes to perineural HIV gp120 with ddC-related neuropathic pain in rats.
Topics: Animals; Anti-HIV Agents; Disease Models, Animal; Gene Expression Regulation; HIV Envelope Protein gp120; Humans; Hyperalgesia; Male; Membrane Proteins; mRNA Cleavage and Polyadenylation Factors; Neuralgia; Oligodeoxyribonucleotides, Antisense; Pain Management; Pain Threshold; Phosphoproteins; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Spinal Cord; Succinate Dehydrogenase; Transcription Factors; Zalcitabine | 2016 |
Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.
Topics: Alcoholic Neuropathy; Animals; Anti-HIV Agents; Disease Models, Animal; Drug Interactions; Electron Transport Chain Complex Proteins; Ethanol; Hyperalgesia; Male; Mitochondria; Oligodeoxyribonucleotides, Antisense; Peripheral Nervous System Diseases; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Zalcitabine | 2010 |
Role of Drp1, a key mitochondrial fission protein, in neuropathic pain.
Topics: Analysis of Variance; Animals; Anti-HIV Agents; Antineoplastic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dynamins; Epinephrine; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Hydrogen Peroxide; Hyperalgesia; Male; Nerve Growth Factor; Neuralgia; Nitric Oxide Donors; Nitro Compounds; Oligodeoxyribonucleotides, Antisense; Organoplatinum Compounds; Oxaliplatin; Pain Measurement; Quinazolinones; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha; Zalcitabine | 2011 |
The correlation between pain-related behaviour and spinal microgliosis in four distinct models of peripheral neuropathy.
Topics: Animals; Anti-HIV Agents; Behavior, Animal; Disease Models, Animal; Flow Cytometry; Gliosis; Herpes Zoster; Herpesvirus 3, Human; HIV Envelope Protein gp120; HIV Infections; Hyperalgesia; Immunohistochemistry; Male; Microglia; Peripheral Nerve Injuries; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Spinal Cord; Spinal Nerves; Zalcitabine | 2012 |
Caspase signalling in neuropathic and inflammatory pain in the rat.
Topics: Animals; Caspase Inhibitors; Caspases; Ceramides; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Epinephrine; Hyperalgesia; Male; Neuralgia; Neurogenic Inflammation; Neuroprotective Agents; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin; Time Factors; Tumor Necrosis Factor-alpha; Vincristine; Zalcitabine | 2004 |
Mitochondrial electron transport in models of neuropathic and inflammatory pain.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Antimycin A; Disease Models, Animal; Drug Interactions; Electron Transport; Enzyme Inhibitors; Hyperalgesia; Male; Mitochondria; Multienzyme Complexes; Neuralgia; Neurogenic Inflammation; Pain Measurement; Pain Threshold; Peripheral Nerves; Rats; Rats, Sprague-Dawley; Rotenone; Streptozocin; Time Factors; Uncoupling Agents; Vincristine; Zalcitabine | 2006 |
Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain.
Topics: Animals; Anti-Bacterial Agents; Anti-HIV Agents; Chemokine CCL2; Cold Temperature; Disease Models, Animal; Epidermis; Ganglia, Spinal; Gliosis; HIV Envelope Protein gp120; Hot Temperature; Hyperalgesia; Male; Minocycline; Motor Activity; Nerve Fibers; Nerve Tissue Proteins; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Zalcitabine | 2007 |
Alcohol-induced stress in painful alcoholic neuropathy.
Topics: Adrenalectomy; Alcoholic Neuropathy; Alcohols; Analysis of Variance; Animals; Drug Interactions; Epinephrine; Hormone Antagonists; Hyperalgesia; Male; Mifepristone; Neuralgia; Oligonucleotides, Antisense; Paclitaxel; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Receptors, Glucocorticoid; Stress, Physiological; Time Factors; Zalcitabine | 2008 |